Quotazioni in diretta

TNXP Tonix Pharmaceuticals Holding Corporation

0,171

-0,011 (-6,04%)

11 Mag 2024 - Chiuso

Dati in Delay di 15 minuti

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Grafico Azioni Tonix Pharmaceuticals (NASDAQ:TNXP)
Storico
Da Apr 2024 a Mag 2024

Clicca qui per i Grafici di Tonix Pharmaceuticals

Grafico Azioni Tonix Pharmaceuticals (NASDAQ:TNXP)
Storico
Da Mag 2023 a Mag 2024

Clicca qui per i Grafici di Tonix Pharmaceuticals

Notizie Tonix Pharmaceuticals Holding Corporation - TNXP

Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
Mercoledì 24 Aprile 2024 (3 settimane fa) • GlobeNewswire Inc.

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Lunedì 1 Aprile 2024 (1 mese fa) • GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
Giovedì 28 Marzo 2024 (1 mese fa) • GlobeNewswire Inc.

Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
Lunedì 25 Marzo 2024 (2 mesi fa) • GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting
Giovedì 21 Marzo 2024 (2 mesi fa) • GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia
Mercoledì 20 Marzo 2024 (2 mesi fa) • GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024
Martedì 19 Marzo 2024 (2 mesi fa) • GlobeNewswire Inc.

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring
Martedì 12 Marzo 2024 (2 mesi fa) • GlobeNewswire Inc.

Form 8-K - Current report
Lunedì 11 Marzo 2024 (2 mesi fa) • Edgar (US Regulatory)

Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia
Lunedì 11 Marzo 2024 (2 mesi fa) • GlobeNewswire Inc.

New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT
Giovedì 7 Marzo 2024 (2 mesi fa) • GlobeNewswire Inc.

Form 8-K - Current report
Giovedì 7 Marzo 2024 (2 mesi fa) • Edgar (US Regulatory)

Più Tonix Pharmaceuticals Holding Corporation Articoli Notizie

Intesa Sanpaolo

Banca Monte Dei Paschi D...

Mediobanca Banca di Cred...

ST Microelectronics

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea